Cost-effectiveness of counselling, graded-exercise and usual care for chronic fatigue: evidence from a randomised trial in primary care

• Published in: BMC health services research 2012-08, Vol.12 (1), p.264-264, Article 264
• Main Authors: Sabes-Figuera, Ramon, McCrone, Paul, Hurley, Mike, King, Michael, Donaldson, Ana Nora, Ridsdale, Leone
• Format: Article
• Language: English
• Subjects: Adult; Care and treatment; Chronic fatigue; Chronic fatigue syndrome; Clinical outcomes; Cognition & reasoning; Cost analysis; Cost-Benefit Analysis; Cost-effectiveness; Counseling; Counseling - economics; Counseling - statistics & numerical data; Economic aspects; England; Exercise Therapy - economics; Exercise Therapy - statistics & numerical data; Family medicine; Fatigue; Fatigue Syndrome, Chronic - psychology; Fatigue Syndrome, Chronic - therapy; Female; Follow-Up Studies; Health Care Costs - statistics & numerical data; Health counseling; Humans; Male; Medical care, Cost of; Middle Aged; Patients; Primary care; Primary Health Care - methods; Randomised controlled trial; Self Care; Self help; Treatment Outcome
• ISSN: 1472-6963; 1472-6963
• DOI: 10.1186/1472-6963-12-264

Fatigue is common and has been shown to result in high economic costs to society. The aim of this study is to compare the cost-effectiveness of two active therapies, graded-exercise (GET) and counselling (COUN) with usual care plus a self-help booklet (BUC) for people presenting with chronic fatigue. A randomised controlled trial was conducted with participants consulting for fatigue of over three months' duration recruited from 31 general practices in South East England and allocated to one of three arms. Outcomes and use of services were assessed at 6-month follow-up. The main outcome measure used in the economic evaluation was clinically significant improvements in fatigue, measured using the Chalder fatigue scale. Cost-effectiveness was assessed using the net-benefit approach and cost-effectiveness acceptability curves. Full economic and outcome data at six months were available for 163 participants; GET = 51, COUN = 58 and BUC = 54. Those receiving the active therapies (GET and COUN) had more contacts with care professionals and therefore higher costs, these differences being statistically significant. COUN was more expensive and less effective than the other two therapies. The incremental cost-effectiveness ratio of GET compared to BUC was equal to £987 per unit of clinically significant improvement. However, there was much uncertainty around this result. This study does not provide a clear recommendation about which therapeutic option to adopt, based on efficiency, for patients with chronic fatigue. It suggests that COUN is not cost-effective, but it is unclear whether GET represents value for money compared to BUC. Clinical Trial Registration number at ISRCTN register: 72136156.